antibody therapies for aml and mds
Published 3 years ago • 112 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
1:28
cd47 antibodies for the treatment of aml and mds: where is the field moving?
-
3:34
anti-cd47 antibodies & azacitidine for aml and mds
-
1:41
the role of antibody-based therapies in mds treatment
-
1:24
antibodies for the treatment of mds: magrolimab & sabatolimab
-
1:33
antibody-based therapy to treat aml: radioimmunoconjugates
-
2:20
promising novel antibody therapies for aml
-
1:13
expanding treatment options for aml to patients with mds
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
1:26
effective immunomodulation with pomalidomide during induction tst for aml and mds
-
3:50
antibody-based therapy in aml: immunotoxins and bites
-
2:54
novel therapies in aml and mds
-
1:02
bispecific agents: the future of aml and mds treatment?
-
1:36
innovations in mds and aml treatment
-
2:38
advances in immunotherapy for mds: anti-tim-3 & anti-cd47 antibodies and small molecule inhibitors
-
1:18
the mechanism of action of anti-cd47 antibodies & where these may fit in the mds treatment landscape
-
1:09
differences and similarities between mds and aml & how this can inform treatment decisions
-
5:20
targeted therapies in aml: menin, flt3 and idh inhibitors
-
1:41
the future of aml and mds diagnosis and treatment
-
1:58
mrd as a surrogate endpoint for aml therapy